Autres langues

02/10/17 Alere : Receives FDA Clearance for Alere™ i Influenza A & B 2 Rapid Molecular Test
02/10/17 Alere : Receives FDA Clearance for Alere(TM) i Influenza A & B 2 Rapid Molecular Test
29/09/17 Alere : Announces the U.S. Department of Justice Closes Investigation
29/09/17 Alere : Abbott Acquisition of Alere Set to Close on October 3, 2017
29/09/17 Alere : Announces Agreement in Principle to Settle with the U.S. Department of Justice
28/09/17 Alere : Announces Settlement with SEC
19/09/17 Alere : Announces Intent to Voluntarily Delist Series B Convertible Perpetual Preferred Stock from the NYSE Conditioned Upon the Completion of its Acquisition by Abbott
19/09/17 Alere Inc. : Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
16/09/17 ALERE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alere Inc. - ALR
09/09/17 ALERE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alere Inc. - ALR
02/09/17 ALERE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alere Inc. - ALR
11/08/17 Alere : Provides Notice to Holders of Series B Convertible Perpetual Preferred Stock
03/08/17 Alere : Reports Second Quarter 2017 Financial Results
31/07/17 Alere : Immunalysis Receives FDA Clearance for SEFRIA(TM) Fentanyl Urine Drug Screening Test
20/07/17 Abbott Laboratories : profit forecast gets a lift from St. Jude integration
19/07/17 Alere : Launches Alere iCup® Rx Drug Screen for Detecting Commonly Misused and Abused Prescription Drugs
07/07/17 Alere : Shareholders Approve Amended Merger with Abbott
23/06/17 Alere Inc. : Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
14/06/17 Alere : Reports First Quarter 2017 Financial Results
05/06/17 Alere : Announces Termination of Consent Solicitations for Alere Inc.’s Notes and Offers Consent Termination Fee
05/06/17 Alere Inc. : Announces Termination of Consent Solicitations for Alere Inc. :'s Notes and Offers Consent Termination Fee
05/06/17 Alere : Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results
01/06/17 Alere : Announces Commencement of Additional Consent Solicitations for Alere Inc.’s Notes
01/06/17 Alere Inc. : Announces Commencement of Additional Consent Solicitations for Alere Inc. :'s Notes
22/05/17 Alere : Announces Update on Form 10-K and Provides Preliminary Unaudited Financial Results
Aucun résultat pour cette recherche